Clinical trial
Study Evaluating Multiple Oral Doses of PPM-204 in Healthy Japanese Male…
NCT00448032 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00448032 |
|---|---|
| Title | Study Evaluating Multiple Oral Doses of PPM-204 in Healthy Japanese Male Subjects |
| Official title | A Multiple Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of Ppm-204 Administered Orally to Healthy Male Japanese Subjects |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | PPM-204 |
| Start date | Nov 1, 2006 |
| Completion | Mar 1, 2007 |
| First posted | Mar 15, 2007 |
| Last update posted | Dec 5, 2007 |
| Countries | Japan |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: